Avantis Emerging Markets ex China Equity ETF (AVXC) Quote

Freaking HUGE money behind this! And they want to grow it like a mother f’er! Look!

https://x.com/thewingfai/status/1786072433201471738?s=46&t=BhTJBtmkPHgCEZtP09Ehxw

I am shocked with how awesome this stock has been over the past couple of days!

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174341897

TPT announced acquiring controlling stake of $200m+ revenue company..easy hold.

Sounds like an assumption but i can dig it

You're welcome. It doesn't happen often for me, maybe every 2-3 years and never a big fill.

I remain onboard with this stock. They take actions that need to be taken in a reasonable way and they report those actions to the shareholders just as they should.
I have stated before pn this board that I see the management of BLFR as competent and responsible.
With the resources the

Why? Delisting ..

The IT term is GIGO.

No need to rush...

LMAO!

https://www.jp3e.com/john-park

We need a buzzword—or phrase—to signify Zebra’s Law being applied to obesity programs!

Suggestions?


Not sure what Zebra's law is but....

Making Obesity Never Effect You (MONEY)

Yes I know it should be affect you, not effect you but

Cup and Handle ????

Check the weekly:

https://i.ibb.co/pb3sYHz/IMG-5825.jpg

Good to know, thanks

bought ATOM $4.07 looks to be reversing

I know what is going on. Nothing. For years. There last report was 2015. Newmin is at least 86 years old.
Company Details
Industry
Biotechnology
Sector
Health Care/Life Sciences
Fiscal Year End
11/2015
Revenue
$49.32K
Sales Growth

Nothing to see here in this play, so statement "or go home" is what will occur.

So whats the final verdict on the random deposits of $0.01/02 some people are seeing in their accounts? Nothing???

What’s a lie? Please share

OTCM has never said VXIT is a “shell” they simply flagged them as a “shell risk”. Looks like Vxit is working to get that removed


The Issuer has provided written representation that, based on personal knowledge, review of public

From my perspective if you are putting together an archery team, you select the members based upon who is closest to the bullseye. Hence why you see many preclinical and early clinical development deals. BP can afford a few misses as long as they get one that nails the bullseye in company making f

Need some big Slaps here.....

Yep, on a huge dollar volume of 700. 😀

https://www.starlink.com/business/direct-to-cell